Literature DB >> 8921231

Expression of interleukin-15 and its receptor by human fetal retinal pigment epithelial cells.

N Kumaki1, D M Anderson, D Cosman, S Kumaki.   

Abstract

PURPOSE: IL-15 and IL-15 receptor expression was measured in retinal pigment epithelial (RPE) cells to support a possible role of IL-15 in ocular inflammatory and immune responses.
METHODS: Reverse transcription-coupled polymerase chain reaction (RT-PCR) and Northern blot analysis of IL-15 mRNA in previously characterized non-transformed and simian virus (SV)-40 transformed human fetal RPE cells were carried out. Biological activities of IL-15 produced by the RPE cells were assayed by co-culture with IL-15 responsive cells. Expression of the IL-15 receptor (IL-15R) alpha, IL-2R beta and gamma chains were examined by RT-PCR.
RESULTS: Both non-transformed and SV-40 transformed human fetal RPE cells express IL-15, a T cell growth factor which has similar biological activities to IL-2, and the expression of IL-15 is enhanced by interferon-gamma (IFN-gamma) or tumor necrosis factor-alpha (TNF-alpha) stimulation. In addition, transcripts for all three IL-15 receptor components (IL-15R alpha, IL-2R beta and IL-2R gamma) were detected in these cells.
CONCLUSIONS: RPE cells produce IL-15, which may play an important role in ocular immune and inflammatory responses by stimulating infiltrated T cells and RPE cells via paracrine and autocrine loops, respectively.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8921231     DOI: 10.3109/02713689609017629

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  2 in total

Review 1.  Major histocompatibility complex molecules on parenchymal cells of the target organ protect against autoimmune disease.

Authors:  Hui Shao; Henry J Kaplan; Deming Sun
Journal:  Chem Immunol Allergy       Date:  2007

2.  Leukocyte diapedesis in vivo induces transient loss of tight junction protein at the blood-retina barrier.

Authors:  Heping Xu; Rosemary Dawson; Isabel J Crane; Janet Liversidge
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-07       Impact factor: 4.799

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.